Abstract
Severe cortex lesions in the hippocampal, parahippocampal and medial temporal lobe (MTL) of Alzheimers disease subjects have been observed by functional magnetic resonance imaging (fMRI) during memory task performance. To date, fMRI technology has not been used to investigate the frontal lobe function of Alzheimers subjects. This study determines if fMRI can be used to assess altered prefrontal cortex activity during Stroop task performance in subjects wih mild cognitive impairment (MCI) and Alzheimers disease (AD). Functional magnetic resonance imaging (fMRI) was performed on 9 healthy elderly controls, 9 subjects with mild cognitive impairment and 10 patients with Alzheimers disease, to examine the prefrontal changes in fMRI activation in relation to the Stroop color-word paradigm. In comparison with controls, MCI subjects showed distinctly increased cortex activity including: the dorsal anterior cingulate, bilateral middle and inferior frontal gyri, bilateral inferior parietal lobule, and the bilateral insular. In contrast, AD subjects exhibited decreased fMRI responses in the regions of the prefrontal cortex listed above. These results imply two different neurophysiological characteristics of MCI and AD. In MCI, a compensatory activity of the prefrontal cortex is observed, whereas in AD a dysfunction of the prefrontal cortex is indicated.
Keywords: Alzheimer's disease, Mild cognitive impairment, Stroop task, fMri
Current Alzheimer Research
Title: An fMRI Stroop Task Study of Prefrontal Cortical Function in Normal Aging, Mild Cognitive Impairment, and Alzheimers Disease
Volume: 6 Issue: 6
Author(s): Chuanming Li, Jian Zheng, Jian Wang, Li Gui and Chuan Li
Affiliation:
Keywords: Alzheimer's disease, Mild cognitive impairment, Stroop task, fMri
Abstract: Severe cortex lesions in the hippocampal, parahippocampal and medial temporal lobe (MTL) of Alzheimers disease subjects have been observed by functional magnetic resonance imaging (fMRI) during memory task performance. To date, fMRI technology has not been used to investigate the frontal lobe function of Alzheimers subjects. This study determines if fMRI can be used to assess altered prefrontal cortex activity during Stroop task performance in subjects wih mild cognitive impairment (MCI) and Alzheimers disease (AD). Functional magnetic resonance imaging (fMRI) was performed on 9 healthy elderly controls, 9 subjects with mild cognitive impairment and 10 patients with Alzheimers disease, to examine the prefrontal changes in fMRI activation in relation to the Stroop color-word paradigm. In comparison with controls, MCI subjects showed distinctly increased cortex activity including: the dorsal anterior cingulate, bilateral middle and inferior frontal gyri, bilateral inferior parietal lobule, and the bilateral insular. In contrast, AD subjects exhibited decreased fMRI responses in the regions of the prefrontal cortex listed above. These results imply two different neurophysiological characteristics of MCI and AD. In MCI, a compensatory activity of the prefrontal cortex is observed, whereas in AD a dysfunction of the prefrontal cortex is indicated.
Export Options
About this article
Cite this article as:
Li Chuanming, Zheng Jian, Wang Jian, Gui Li and Li Chuan, An fMRI Stroop Task Study of Prefrontal Cortical Function in Normal Aging, Mild Cognitive Impairment, and Alzheimers Disease, Current Alzheimer Research 2009; 6 (6) . https://dx.doi.org/10.2174/156720509790147142
DOI https://dx.doi.org/10.2174/156720509790147142 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Deep Learning for Advancing Alzheimer's Disease Research
Alzheimer's disease (AD) poses a significant global health challenge, with an increasing number of individuals affected yearly. Deep learning, a subfield of artificial intelligence, has shown immense potential in various domains, including healthcare. This thematic issue of Current Alzheimer Research explores the application of deep learning techniques in advancing our ...read more
Diagnostic and therapeutic biomarkers of dementia
Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Current Targets for Anticancer Drug Discovery
Current Drug Targets Gender Hormones: Role in the Pathogenesis of Central Nervous System Disease and Demyelination
Current Neurovascular Research Bone Marrow Microenvironment: A Newly Recognized Target for Diabetes- Induced Cellular Damage
Endocrine, Metabolic & Immune Disorders - Drug Targets Repositioning of Drugs in Cardiometabolic Disorders: Importance and Current Scenario
Current Topics in Medicinal Chemistry Senescence of the Brain: Focus on Cognitive Kinases
Current Pharmaceutical Design The Vascular Component of Alzheimer`s Disease
Current Neurovascular Research Cerebrolysin Attenuates Heat Shock Protein (HSP 72 KD) Expression in the Rat Spinal Cord Following Morphine Dependence and Withdrawal: Possible New Therapy for Pain Management
Current Neuropharmacology Adrenomedullin in Heart Failure: Molecular Mechanism and Therapeutic Implication
Current Hypertension Reviews The First Approved Agent in the Glitazar’s Class: Saroglitazar
Current Drug Targets Inhibition of DNA Polymerase λ Suppresses 12-O-Tetradecanoylphorbol- 13-Acetate-Induced Inflammation
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Clinical Evidence of Intravitreal Triamcinolone Acetonide in the Management of Age-Related Macular Degeneration
Current Drug Targets In Vitro Modeling of the Blood-Brain Barrier: Simplicity Versus Complexity
Current Pharmaceutical Design Preparation and Characterization of 5-Fluorouracil Loaded Nanogels for Skin Cancer Treatments: In Vitro Drug Release, Cytotoxicity and Cellular Uptake Analysis
Current Nanomedicine A Combination of 3D-QSAR Modeling and Molecular Docking Approach for the Discovery of Potential HIF Prolyl Hydroxylase Inhibitors
Medicinal Chemistry Recent Developments in the Regulation of Monoamine Oxidase Form and Function: Is the Current Model Restricting Our Understanding of the Breadth of Contribution of Monoamine Oxidase to Brain [dys]Function?
Current Topics in Medicinal Chemistry Gambogic Acid is a Novel Anti-cancer Agent that Inhibits Cell Proliferation, Angiogenesis and Metastasis
Anti-Cancer Agents in Medicinal Chemistry Therapeutic Approaches of Leptin in Alzheimers Disease
Recent Patents on CNS Drug Discovery (Discontinued) Inhibition of Tumor Angiogenesis by Antibodies, Synthetic Small Molecules and Natural Products
Current Medicinal Chemistry Nitric Oxide Mimetic Molecules as Therapeutic Agents in Alzheimers Disease
Current Alzheimer Research Microcirculation in Sepsis: New Perspectives
Current Vascular Pharmacology